Posted on 06/17/2020 7:25:12 AM PDT by SeekAndFind
Another blow for the corporate media and their panic porn about COVID-19. According to scientists in the U.K., the inexpensive and generic dexamethasone is showing life-saving results. This is great news for patients suffering from serve COVID-19 in the future. The sad part is this is a treatment for the symptoms of a cytokine storm, an overactive immune response, not the virus itself.
This is frustrating because doctors in the United States have been pushing this theory for months. Pulmonologist Dr. Thomas Yadegar, ICU director of Providence Cedars-Sinai, was treating critically ill patients with powerful anti-inflammatories like dexamethasone based on their inflammatory lab profile in March:
In the interview, he said COVID-19 actually causes two problems. The first is an infectious upper respiratory disease caused by the virus which may be anything from asymptomatic to severe. It can cause complications similar to severe influenza such as pneumonia and may still be deadly in compromised patients.
However, the majority of patients coming into their ICU displaying rapid deterioration and requiring ventilation have inflammatory markers consistent with Cytokine Storm Syndrome. This syndrome is an overactivation of the patient’s own immune system. It causes the patient’s own immune defenses to attack their organs. They are basically suffering from an induced autoimmune disorder which can cause the full range of complications, depending on the patient, including atypical clots and myocarditis that are being reported.
Dr. Yadegar went on to say the medications and treatment provided depended on the individual labs and body systems being affected by the overactive immune response. This got almost no notice in the corporate media, possibly because, at the time, Dr. Yadegar and his team had treated approximately 35 patients with severe COVID-19 and none had deteriorated
(Excerpt) Read more at pjmedia.com ...
MORE FROM THE UK:
https://www.bbc.com/news/health-53061281
In the trial, led by a team from Oxford University, about 2,000 hospital patients were given dexamethasone and compared with more than 4,000 who were not.
For patients on ventilators, it cut the risk of death from 40% to 28%. For patients needing oxygen, it cut the risk of death from 25% to 20%.
Chief investigator Prof Peter Horby said: “This is the only drug so far that has been shown to reduce mortality – and it reduces it significantly. It’s a major breakthrough.”
Seeing these old meds pop up for use at different stages of the virus makes me lean more and more to lab made virus.
The authors of the article are accepting a snow job given by the Oxford folks who did the “study”.
Why do I say a “snow job”?
Because the authors of the study and the “reporters are all either ignorant of what is already happening in the health care field with regard to treating sever Wuhan Virus cases or they are intentionally negligent in not admitting what is already being done.
How so? The cytokine storm seen in many severe Wuhan Virus cases is well known and well understood. AND patients are already being treated with other steroids to quiet the cytokine storm and those other steroids are already saving lives. Dexamethasone is another steroid. And if it’s cost/price is now cheaper but every panics into thinking it is some “miracle” - which it is not, then maybe the main manufacturer - Aspen Bad Oldesloe GmbH, 32-36 Industriestrasse, 23843 Bad Oldesloe, Germany - will be able to raise the price, globally. Which makes me wonder who paid for the Oxford study.
As to:
“promising work in the United States to be suppressed that could have saved countless lives if broadly communicated.”
B.S. All the top infectious disease doctors in the U.S. know about the cytokine storm, know about the use of steroids to treat it, and know about research and developments of using the right combinations of medicines tailored to the patient. Nothing is being “suppressed. I have learned that from a top NY infectious disease doctor is the wife of a nephew of mine.
In re: “The good news about dexamethasone highlights an unmitigated failure in our global and national health organizations.”
More B.S. Notice how the article and more importantly refuses to note if the “study” included patients given different steroids instead of Dexamethasone. Of course the difference in outcomes ought to be fantastic if it is a question of Dexamethasone vs no steroids at all. But what about the outcomes if it is Dexamethasone vs methylprednisolone - a steroid already in use with some severe Wuhan Virus cases. A true “study” would have demonstrated (a) differences in side affects and (b) differences in outcomes between Dexamethasone and other steroids. Given that other steroids are already in use, Dexamethasone vs no steroids is not a valid comparison, because there are alternatives and the “study” pretends no steroid alternatives exist.
The trick is to know the patient really needs it because if your wrong you could kill them.
My guess is that the study was designed and conducted before other steroids began to be explored and used for COVID 19. Plausibly, a meta analysis may point toward the comparisons that you suggest. The sponsor (Oxford) and collaborators listed for the study seem on the level.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.